Directory
>
Andres Ruiz Briseno
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations | IDEAYA Biosciences
San Francisco, California, United States
Andres Ruiz Briseno
Summary
Andres Ruiz Briseno is a seasoned finance executive with extensive experience in the life sciences sector, particularly in biotech. He has a proven track record of leading financial operations for high-stakes projects, including the launch of the cancer drug IMBRUVICA. His expertise encompasses a wide range of financial disciplines, from accounting and auditing to strategic planning and investor relations. Andres is known for his collaborative approach, working closely with senior management to drive business strategies and enhance operational efficiency. His background in public accounting with a Big 4 firm has equipped him with a strong foundation in compliance and financial controls. He is also recognized for his leadership in developing and mentoring finance teams. With a degree in Business Administration focused on Corporate Financial Management, he combines technical acumen with strong business insight.
Andres Ruiz Briseno
Work Experience
Senior Vice President, Head of Finance and Investor Relations at
IDEAYA Biosciences
July 2023 - Present
Advisory Board Member at
Drug Hunter
February 2022 - July 2024
Vice President, Head of Business Operations and Investor Relations at
IDEAYA Biosciences
November 2021 - July 2023
Vice President, Finance at
IDEAYA Biosciences
July 2019 - July 2021
Controller at
IDEAYA Biosciences
August 2016 - June 2019
Associate Director, Financial Planning & Analysis at
Pharmacyclics, an AbbVie Company
September 2013 - August 2016
Associate Manager of Finance at
Theravance Biopharma US, Inc.
January 2012 - September 2013
Senior Associate, Life Sciences and Venture Capital at
PwC
January 2009 - January 2012
Andres Ruiz Briseno
Education
January 2005 - January 2009
Frequently Asked Questions about Andres Ruiz Briseno
What is Andres Ruiz Briseno email address?
Andres Ruiz Briseno's primary email address is ***********@att.net. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andres Ruiz Briseno work for?
Andres Ruiz Briseno is a Senior Vice President, Head of Finance and Investor Relations at IDEAYA Biosciences, a company specializing in Commercial physical research.
Where Andres Ruiz Briseno graduated from?
Andres Ruiz Briseno holds a degree in Business Administration, Concentration-Corporate Financial Management from San José State University.
How can I directly contact Andres Ruiz Briseno?
To contact Andres Ruiz Briseno directly, you can use the email address ***********@att.net. Complete contact information is available upon registration with Muraena.
Who is Andres Ruiz Briseno?
Andres Ruiz Briseno is a seasoned finance executive with extensive experience in the life sciences sector, particularly in biotech. He has a proven track record of leading financial operations for high-stakes projects, including the launch of the cancer drug IMBRUVICA. His expertise encompasses a wide range of financial disciplines, from accounting and auditing to strategic planning and investor relations. Andres is known for his collaborative approach, working closely with senior management to drive business strategies and enhance operational efficiency. His background in public accounting with a Big 4 firm has equipped him with a strong foundation in compliance and financial controls. He is also recognized for his leadership in developing and mentoring finance teams. With a degree in Business Administration focused on Corporate Financial Management, he combines technical acumen with strong business insight.
Andres`s contact details
***********@att.net
********@ideayabio.com
Colleagues
Chief Technology Officer, Head of Drug Discovery
Senior Vice President, Head of Development Operations
Chief Scientific Officer
VP and Head of Medicinal Chemistry
Chief Medical Officer
Vice President, and Head, Pharmacology and Toxicology
Vice President Early Oncology Clinical Development
Vice President, Head of CMC
Vice President, Clinical Operations